Boston Family Office LLC increased its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,445 shares of the pharmacy operator’s stock after buying an additional 1,125 shares during the period. Boston Family Office LLC’s holdings in Walgreens Boots Alliance were worth $2,113,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in WBA. Norges Bank acquired a new stake in Walgreens Boots Alliance during the fourth quarter worth about $649,813,000. Viking Global Investors LP increased its stake in Walgreens Boots Alliance by 562.8% in the fourth quarter. Viking Global Investors LP now owns 7,899,951 shares of the pharmacy operator’s stock worth $653,800,000 after buying an additional 6,708,040 shares during the period. Glenview Capital Management LLC acquired a new stake in Walgreens Boots Alliance during the fourth quarter worth about $124,140,000. UBS Asset Management Americas Inc. increased its stake in Walgreens Boots Alliance by 22.9% in the first quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock worth $407,982,000 after buying an additional 914,888 shares during the period. Finally, Putnam Investments LLC increased its stake in Walgreens Boots Alliance by 24.5% in the fourth quarter. Putnam Investments LLC now owns 4,090,605 shares of the pharmacy operator’s stock worth $338,539,000 after buying an additional 804,863 shares during the period. Institutional investors and hedge funds own 61.17% of the company’s stock.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded down 0.53% during midday trading on Tuesday, reaching $81.08. The company had a trading volume of 4,036,340 shares. The company has a market cap of $86.76 billion, a PE ratio of 20.47 and a beta of 1.25. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $89.69. The company’s 50-day moving average is $78.70 and its 200 day moving average is $82.37.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The firm had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same quarter last year, the company earned $1.18 EPS. The company’s revenue was up 2.1% on a year-over-year basis. On average, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post $5.01 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date of this dividend is Wednesday, August 16th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 37.78%.

Walgreens Boots Alliance declared that its Board of Directors has approved a stock buyback program on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to repurchase up to 5.9% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s management believes its shares are undervalued.

TRADEMARK VIOLATION NOTICE: “Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Boston Family Office LLC” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/08/08/walgreens-boots-alliance-inc-nasdaqwba-position-raised-by-boston-family-office-llc-updated-updated-updated.html.

Several analysts have issued reports on the stock. Needham & Company LLC raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 price objective for the company in a research report on Friday, June 30th. Pivotal Research set a $85.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Sunday, July 2nd. Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, June 14th. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and set a $77.00 price target (down previously from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Finally, Jefferies Group LLC reduced their price objective on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, May 31st. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $90.69.

In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now owns 19,151 shares in the company, valued at approximately $1,528,058.29. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 13.50% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.